Rxsight Inc (RXST)
13.78 x 1 23.29 x 2
Pre-market by (Cboe BZX)
14.56 -0.39 (-2.61%) 04/28/25 [NASDAQ]
13.78 x 1 23.29 x 2
Pre-market 14.56 unch (unch) 16:00 ET
for Mon, Apr 28th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -27,455 | -48,608 | -66,756 | -48,688 | 27,575 |
Depreciation Amortization | -5,353 | -1,592 | 3,169 | 4,451 | 3,651 |
Accounts receivable | -9,803 | -9,325 | -6,094 | -1,996 | -2,076 |
Accounts payable and accrued liabilities | 946 | 1,250 | 635 | 555 | -954 |
Other Working Capital | -9,211 | -9,072 | -7,412 | -2,678 | -7,848 |
Other Operating Activity | 33,930 | 25,754 | 17,608 | 3,648 | -55,551 |
Operating Cash Flow | $-16,946 | $-41,593 | $-58,850 | $-44,708 | $-35,203 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -93,871 | -17,315 | 42,343 | -79,967 | 18,127 |
PPE Investments | -5,440 | -4,814 | -2,393 | -1,940 | -2,536 |
Investing Cash Flow | $-99,311 | $-22,129 | $39,950 | $-81,907 | $15,591 |
Cash Flows From Financing Activities | |||||
Debt Issued | N/A | 20,000 | N/A | 15,000 | 25,000 |
Debt Repayment | -4,829 | -61,576 | -764 | -27 | -142 |
Common Stock Issued | 128,916 | 105,957 | 7,828 | 121,136 | 992 |
Other Financing Activity | -768 | -2,857 | -732 | 1,233 | -613 |
Financing Cash Flow | $123,319 | $61,524 | $6,332 | $137,342 | $25,237 |
Exchange Rate Effect | -9 | 6 | -9 | -10 | N/A |
Beginning Cash Position | 10,403 | 12,595 | 25,172 | 14,455 | 8,830 |
End Cash Position | 17,456 | 10,403 | 12,595 | 25,172 | 14,455 |
Net Cash Flow | $7,053 | $-2,192 | $-12,577 | $10,717 | $5,625 |
Free Cash Flow | |||||
Operating Cash Flow | -16,946 | -41,593 | -58,850 | -44,708 | -35,203 |
Capital Expenditure | -5,440 | -4,814 | -2,393 | -1,940 | -2,539 |
Free Cash Flow | -22,386 | -46,407 | -61,243 | -46,648 | -37,742 |